Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HAIC plus sorafenib vs TACE plus sorafenib in advanced HCC (SHATA-001)
NCT02856126Phase 3Completed
- Sponsor
- Sun Yat-sen University
- Start
- Aug 2016
- Primary completion
- Oct 2020
- Modality
- DNA Intercalators/Alkylators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of oxaliplatin, fluorouracil, folinic acid in hepatocellular carcinoma (HCC), sponsored by Sun Yat-sen University. Started Aug 2016; status: completed.
02
Drugs
oxaliplatinfluorouracilfolinic acid
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT02856126.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02856126.